Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06939517 · ClinicalTrials.gov registry record · NA
Acupressure Wristbands for GLP-1RA Related Nausea
A NA study of Nausea, sponsored by Florencia Ziemke.
- Active
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT06939517 is a NA study of Nausea that is active but no longer recruiting, run by Florencia Ziemke. The registered enrollment target is 35 participants, below the 242-participant average among 17 other Nausea trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06939517, a NA study of Nausea, is active but no longer recruiting, sponsored by Florencia Ziemke.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
Nausea is a common side effect of GLP-1RA medications used for treatment of Type 2 diabetes mellitus and obesity. Current recommendations for nausea relief include the use of dietary changes and prescription anti-emetics. Acupressure wristbands Sea-Band are FDA cleared for nausea relief in other indications such as motion sickness, morning sickness in pregnancy, post-operative nausea, chemotherapy associated nausea. We hypothesized that acupressure wristbands could alleviate nausea in persons taking GLP-1RA.
Conditions Studied
Interventions
- DEVICE SeaBand
Study Locations (1)
Florida
- Evexia Medical - Jupiter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2025-04-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06939517
The ClinicalTrials.gov registry entry for NCT06939517 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 242-participant average among 17 other Nausea trials with a reported enrollment target (86% lower). The listed sponsor is Florencia Ziemke, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nausea appearing as the primary indexed condition, and to 1 intervention - of which SeaBand is the first listed.
NCT06939517 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06939517 about?
NCT06939517 is a clinical study titled "Acupressure Wristbands for GLP-1RA Related Nausea". Nausea is a common side effect of GLP-1RA medications used for treatment of Type 2 diabetes mellitus and obesity. Current recommendations for nausea relief include the use of dietary changes and prescription anti-emetics. Acupressure wristbands Sea-Band are FDA cleared for nausea relief in other ind...
What is the current status of trial NCT06939517?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2024-02-01. Estimated completion is 2025-04-13.
What conditions does trial NCT06939517 study?
This clinical trial studies the following conditions: Nausea.
What interventions are being tested in trial NCT06939517?
The interventions under investigation include: SeaBand (DEVICE).
Who is sponsoring clinical trial NCT06939517?
This trial is sponsored by Florencia Ziemke, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06939517 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nausea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting
RECRUITING · NA
-
Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
RECRUITING · NA
-
Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment
RECRUITING · NA
-
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
COMPLETED · NA
-
Virtual Reality at End-of-life
COMPLETED · NA
-
Inhaled Isopropyl Alcohol for Treatment of Nausea
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.